Biodexa Pharmaceuticals Has Been Granted U.S. Patent Number 12,011,445 Titled "Prevention Of Pancreatic Cell Degeneration (For The Treatment Of Type I Diabetes)". This Patent Is Licensed From Melior Pharmaceuticals
Biodexa Pharmaceuticals Has Been Granted U.S. Patent Number 12,011,445 Titled "Prevention Of Pancreatic Cell Degeneration (For The Treatment Of Type I Diabetes)". This Patent Is Licensed From Melior Pharmaceuticals
Biodexa藥品公司獲得美國專利號12,011,445，標題爲“預防胰島細胞退化（治療1型糖尿病）”。該專利是由Melior藥品公司授權使用的。
Biodexa Pharmaceuticals Has Been Granted U.S. Patent Number 12,011,445 Titled "Prevention Of Pancreatic Cell Degeneration (For The Treatment Of Type I Diabetes)". This Patent Is Licensed From Melior Pharmaceuticals
Biodexa藥品公司獲得美國專利號12,011,445，標題爲“預防胰島細胞退化（治療1型糖尿病）”。該專利是由Melior藥品公司授權使用的。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。